Document is current
Any future updates will be listed below
-
Authors
Schuch, Fabiane https://orcid.org/0000-0002-5832-9904
Walger, Lennart
Schmitz, Matthias
David, Bastian
Bauer, Tobias
Harms, Antonia
Fischbach, Laura
Schulte, Freya
Schidlowski, Martin https://orcid.org/0000-0003-4268-9291
Reiter, Johannes https://orcid.org/0000-0002-4235-8209
Bitzer, Felix https://orcid.org/0000-0003-2043-8854
von Wrede, Randi
Rácz, Atilla
Baumgartner, Tobias
Borger, Valeri
Schneider, Matthias
Flender, Achim
Becker, Albert
Vatter, Hartmut
Weber, Bernd
Specht-Riemenschneider, Louisa
Radbruch, Alexander
Surges, Rainer
Rüber, Theodor https://orcid.org/0000-0002-6180-7671
- License Information
-
More Information
Article History
Received: 14 November 2022
Accepted: 13 July 2023
First Online: 20 July 2023
Competing interests
: RvW has received travel support, fees as speaker or for serving on the advisory board from Angelini, Apocare, Arvelle, Cerbomed, Desitin, Eisai, GW pharmaceuticals-JAZZ pharma and UCB Pharma. These activities were not related to the content of this manuscript. ARad serves on the scientific advisory boards for GE Healthcare, Bracco, Bayer, Guerbet, and AbbVie; has received speaker honoraria from Bayer, Guerbet, Siemens, and Medscape; and is a consultant for, and has received institutional study support from, Guerbet and Bayer. RS has received fees as speaker or consultant from Angelini, Arvelle, Bial, Desitin, Eisai, Janssen-Cilag GmbH, LivaNova, Novartis, Precisis, UCB Pharma, UnEEG and Zogenix; these activities were unrelated to the work of this manuscript. The other authors declare no competing interests.
